BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 28618984)

  • 21. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
    Lepore G; Dodesini AR; Nosari I; Scaranna C; Corsi A; Trevisan R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):e15-6. PubMed ID: 22673770
    [No Abstract]   [Full Text] [Related]  

  • 22. Albuminuria Reduction after High Dose of Vitamin D in Patients with Type 1 Diabetes Mellitus: A Pilot Study.
    Felício JS; de Oliveira AF; Peixoto AS; de Souza ACCB; Abrahão Neto JF; de Melo FTC; Carvalho CT; de Lemos MN; Cavalcante SDN; Resende FS; Dos Santos MC; Motta AR; Janaú LC; Yamada ES; Felício KM
    Front Endocrinol (Lausanne); 2017; 8():199. PubMed ID: 28855892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
    [No Abstract]   [Full Text] [Related]  

  • 24. Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion.
    Kerr D; Hoogma RP; Buhr A; Petersen B; Storms FE;
    J Diabetes Sci Technol; 2010 Nov; 4(6):1400-7. PubMed ID: 21129336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin.
    Kudva YC; Basu A; Jenkins GD; Pons GM; Vogelsang DA; Rizza RA; Smith SA; Isley WL
    Endocr Pract; 2007; 13(3):244-50. PubMed ID: 17599855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.
    Oliver N; Gimenez M; Calhoun P; Cohen N; Moscardo V; Hermanns N; Freckmann G; Reddy M; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):53-58. PubMed ID: 31530662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.
    Campos-Náñez E; Fortwaengler K; Breton MD
    J Diabetes Sci Technol; 2017 Nov; 11(6):1187-1195. PubMed ID: 28569076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
    Crenier L
    Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous glucose monitors: use of waveform versus glycemic values in the improvements of glucose control, quality of life, and fear of hypoglycemia.
    Walker TC; Yucha CB
    J Diabetes Sci Technol; 2014 May; 8(3):488-93. PubMed ID: 24876611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose Vitamin D Supplementation on Type 1 Diabetes Mellitus Patients: Is there an Improvement in Glycemic Control?
    de Melo FTC; Felício KM; de Queiroz NNM; de Rider Brito HA; Neto JFA; Janaú LC; de Souza Neto NJK; Silva ALA; de Lemos MN; de Oliveira MCNI; de Alcântara AL; de Moraes LV; de Souza ÍJA; Said NM; da Silva WM; de Lemos GN; Dos Santos MC; De Souza D Albuquerque Silva L; Motta ARB; de Figueiredo PBB; de Souza ACCB; Piani PPF; Felício JS
    Curr Diabetes Rev; 2022; 18(1):e010521189964. PubMed ID: 33413064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
    Pfützner A; Weissmann J; Mougiakakou S; Daskalaki E; Weis N; Ziegler R
    Diabetes Technol Ther; 2015 Jun; 17(6):392-7. PubMed ID: 25734860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia.
    van Beers CA; Kleijer SJ; Serné EH; Geelhoed-Duijvestijn PH; Snoek FJ; Kramer MH; Diamant M
    BMC Endocr Disord; 2015 Aug; 15():42. PubMed ID: 26292721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
    Ajjan RA; Jackson N; Thomson SA
    Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
    Monnier L; Wojtusciszyn A; Molinari N; Colette C; Renard E; Owens D
    Diabetes Care; 2020 Apr; 43(4):821-827. PubMed ID: 31988062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study.
    Greven WL; Beulens JW; Biesma DH; Faiz S; de Valk HW
    Diabetes Technol Ther; 2010 Sep; 12(9):695-9. PubMed ID: 20687867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.
    Davey RJ; Jones TW; Fournier PA
    J Diabetes Sci Technol; 2010 Nov; 4(6):1457-64. PubMed ID: 21129341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.